Want to join the conversation?
$ABBV 2Q15 10-Q: On May 26, 2015, ABBV acquired Pharmacyclics through a tender offer for approx. $20.8Bil, including cash consideration of $12.4Bil and equity consideration of $8.4Bil. ABBV entered into and executed a $5Bil ASR agreement with Morgan Stanley on May 26, 2015, pursuant to which ABBV paid $5Bil for initial delivery of 68MM shares.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!
$SGY is expected to achieve $6.17 price target in next year, with a minimum target of $3.00, due to the price increase of 27.85% to $6.29 during the last trading session.